PUBLIC COMPANY
saveMarea Therapeutics Inc
updated 1mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Preclinical
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2A Study to Evaluate MAR002 for Acromegaly
- phase2Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
- phase1Study of MAR002 in Healthy Men
- phase2Study of MAR001 in Adults With Metabolic Dysfunction
- phase2A Mechanistic Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
🐶 Hiring Signal
News
- Lisata deal propels Marea’s drug pipeline to Wall StreetMarea’s acquisition by Lisata, alongside a $225 million financing deal, will back development of a pair of medicines in mid-stage testing for cardiovascular and endocrine conditions.biopharma_dive · 4d ago
- After one failed acquisition attempt, Lisata finds lifeline in Marea mergerAfter a failed merger that led to massive layoffs and a lawsuit, solid tumor biotech Lisata Therapeutics has found a new future through a merger with cardio specialist Marea Therapeutics.fiercebiotech · 4d ago
- Trending: Top biopharma disciplines with jobs live nowFrom engineering to science/R&D, these top seven biopharma disciplines each have hundreds, and in one case over 1,000, positions posted on BioSpace.biospace · 5d ago
- 11 companies hiring in California nowLooking for a biopharma job in California? Check out the BioSpace list of 11 companies hiring life sciences professionals like you.biospace · 12d ago
comments(0)
5-min edit window · permanent after that